Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma

Authors :: Magarotto, V.
Sonneveld, P.
Voorhees, P.
Paba-Prada, C.
Plesner, T.
Mellqvist, U. H.
Byrne, C.
Harmenberg, J.
Nordstrom, E.
Palumbo, A.
Richardson, P.
Source :: Magarotto, V, Sonneveld, P, Voorhees, P, Paba-Prada, C, Plesner, T, Mellqvist, U H, Byrne, C, Harmenberg, J, Nordstrom, E, Palumbo, A & Richardson, P 2015, ' Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma ', Haematologica, vol. 100, no. S1, P285, pp. 89 .
Publication Year :: 2015

Language :: English
Database :: OpenAIRE
Journal :: Magarotto, V, Sonneveld, P, Voorhees, P, Paba-Prada, C, Plesner, T, Mellqvist, U H, Byrne, C, Harmenberg, J, Nordstrom, E, Palumbo, A & Richardson, P 2015, ' Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma ', Haematologica, vol. 100, no. S1, P285, pp. 89 .
Accession number :: edsair.od......3062..7ae8e80ead90333b24487f9be7eb9955

Tools